抵消
发表于 2025-3-23 11:37:47
http://reply.papertrans.cn/88/8765/876444/876444_11.png
匍匐前进
发表于 2025-3-23 16:20:57
Statistics for Biology and Healthhttp://image.papertrans.cn/s/image/876444.jpg
gratify
发表于 2025-3-23 20:59:48
https://doi.org/10.1007/978-1-4939-0005-3Biostatistics; Clinical Trials; Competing Risks; Empirical Likelihood; Mean (Quantile) Residual Life; Mea
Synovial-Fluid
发表于 2025-3-23 23:33:38
http://reply.papertrans.cn/88/8765/876444/876444_14.png
继而发生
发表于 2025-3-24 04:58:46
http://reply.papertrans.cn/88/8765/876444/876444_15.png
grenade
发表于 2025-3-24 08:18:24
http://reply.papertrans.cn/88/8765/876444/876444_16.png
松紧带
发表于 2025-3-24 11:42:49
http://reply.papertrans.cn/88/8765/876444/876444_17.png
发誓放弃
发表于 2025-3-24 18:39:51
Quantile Residual Life,ife function, and derive the quantile residual life process as a Brownian bridge. We also discuss parametric and nonparametric inferences on the quantile residual life function for one-sample, two-sample, and regression settings.
chapel
发表于 2025-3-24 21:28:30
Quantile Residual Life Under Competing Risks,disease-specific endpoint, say time-to-death due to breast cancer. In this case, any death due to other causes that occurs first would preclude a breast-cancer-related death from being observed. In this chapter, we extend the results developed in Chapter 3 to both parametric and nonparametric competing risks settings.
指数
发表于 2025-3-25 00:21:14
http://reply.papertrans.cn/88/8765/876444/876444_20.png